PrimeLink BioTherapeutics
- Biotech or pharma, therapeutic R&D
PrimeLink is a next-generation ADC company redefining targeted therapies with its breakthrough hydrophilic linker technology. Our proprietary platform enables a wide range of ADC mechanisms while significantly broadening the therapeutic window. This advancement unlocks the full potential of treatments designed to deliver deep, durable tumor responses.